PubRank

W A Nolen

Author PubWeight™ 80.89‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Genome-wide association for major depressive disorder: a possible role for the presynaptic protein piccolo. Mol Psychiatry 2008 3.85
2 The Stanley Foundation Bipolar Treatment Outcome Network. II. Demographics and illness characteristics of the first 261 patients. J Affect Disord 2001 2.43
3 Axis I psychiatric comorbidity and its relationship to historical illness variables in 288 patients with bipolar disorder. Am J Psychiatry 2001 2.38
4 [The Depression Recognition Scale: and aid in the diagnosis of depression in family practice]. Ned Tijdschr Geneeskd 1996 2.02
5 Poor replication of candidate genes for major depressive disorder using genome-wide association data. Mol Psychiatry 2010 1.94
6 St John's wort as an antidepressant. BMJ 1996 1.81
7 Prevalence and predictors of recurrence of major depressive disorder in the adult population. Acta Psychiatr Scand 2009 1.66
8 Meta-analysis of genome-wide association data of bipolar disorder and major depressive disorder. Mol Psychiatry 2010 1.63
9 [Undertreatment of depression; causes and recommendations]. Ned Tijdschr Geneeskd 2003 1.61
10 Mood switch in bipolar depression: comparison of adjunctive venlafaxine, bupropion and sertraline. Br J Psychiatry 2006 1.58
11 Genetic risk profiles for depression and anxiety in adult and elderly cohorts. Mol Psychiatry 2010 1.50
12 Relapse prevention in major depressive disorder after successful ECT: a literature review and a naturalistic case series. Acta Psychiatr Scand 2000 1.45
13 An algorithm for the pharmacological treatment of depression. Acta Psychiatr Scand 2009 1.40
14 [Risk of inducing resistance upon stopping and restarting lithium after long-term usage]. Ned Tijdschr Geneeskd 2000 1.38
15 [Subjective side effects of neuroleptic agents]. Ned Tijdschr Geneeskd 1991 1.38
16 [The algorithm for the biological treatment of depression in the Dutch multidisciplinary guideline on depression]. Tijdschr Psychiatr 2011 1.38
17 Determinants of poor 1-year outcome of DSM-III-R major depression in the general population: results of the Netherlands Mental Health Survey and Incidence Study (NEMESIS). Acta Psychiatr Scand 2001 1.31
18 Functional disability and depression in the general population. Results from the Netherlands Mental Health Survey and Incidence Study (NEMESIS). Acta Psychiatr Scand 2004 1.26
19 Validation of the prospective NIMH-Life-Chart Method (NIMH-LCM-p) for longitudinal assessment of bipolar illness. Psychol Med 2000 1.24
20 Are antidepressants safe in the treatment of bipolar depression? A critical evaluation of their potential risk to induce switch into mania or cycle acceleration. Acta Psychiatr Scand 2008 1.19
21 Prevalence of psychopathology in children of a bipolar parent. J Am Acad Child Adolesc Psychiatry 2001 1.17
22 The Stanley Foundation Bipolar Treatment Outcome Network. I. Longitudinal methodology. J Affect Disord 2001 1.11
23 [Physician-assisted suicide for a patient with a psychiatric disorder: guidelines for psychiatrists. Dutch Association of Psychiatry]. Ned Tijdschr Geneeskd 1999 1.09
24 Prevalence of bipolar disorder in the general population: a Reappraisal Study of the Netherlands Mental Health Survey and Incidence Study. Acta Psychiatr Scand 2004 1.08
25 Dimensions of depression, mania and psychosis in the general population. Psychol Med 2004 1.05
26 Care utilization and outcome of DSM-III-R major depression in the general population. Results from the Netherlands Mental Health Survey and Incidence Study (NEMESIS). Acta Psychiatr Scand 2001 1.05
27 Subthreshold depression based on functional impairment better defined by symptom severity than by number of DSM-IV symptoms. J Affect Disord 2009 1.03
28 Recurrence of major depressive disorder and its predictors in the general population: results from the Netherlands Mental Health Survey and Incidence Study (NEMESIS). Psychol Med 2012 1.01
29 The 7-year course of depression and anxiety in the general population. Acta Psychiatr Scand 2011 1.01
30 Carbamazepine, a possible adjunct or alternative to lithium in bipolar disorder. Acta Psychiatr Scand 1983 1.01
31 Open-label adjunctive topiramate in the treatment of bipolar disorders. Biol Psychiatry 2000 0.98
32 Stepped care vs. matched care for mood and anxiety disorders: a randomized trial in routine practice. Acta Psychiatr Scand 2006 0.97
33 Rate of switch in bipolar patients prospectively treated with second-generation antidepressants as augmentation to mood stabilizers. Bipolar Disord 2001 0.96
34 A prospective study of the transition rates of subthreshold (hypo)mania and depression in the general population. Psychol Med 2006 0.95
35 Treatment of unipolar psychotic depression: a randomized, double-blind study comparing imipramine, venlafaxine, and venlafaxine plus quetiapine. Acta Psychiatr Scand 2009 0.94
36 Cognitive dysfunctions and white matter lesions in patients with bipolar disorder in remission. Acta Psychiatr Scand 2000 0.93
37 The effect of moderate and excessive alcohol use on the course and outcome of patients with bipolar disorders: a prospective cohort study. J Clin Psychiatry 2010 0.93
38 The Stanley Foundation Bipolar Network. I. Rationale and methods. Br J Psychiatry Suppl 2001 0.89
39 Methodological issues in developing new acute treatments for patients with bipolar illness. Biol Psychiatry 2000 0.86
40 Experience of negative symptoms: comparison of schizophrenic patients to patients with a depressive disorder and to normal subjects. Am J Psychiatry 1998 0.85
41 Reasons for switching between antipsychotics in daily clinical practice. Pharmacopsychiatry 2005 0.85
42 Determinants of multiple psychotropic drug use in patients with mild intellectual disabilities or borderline intellectual functioning and psychiatric or behavioral disorders. Gen Hosp Psychiatry 2001 0.84
43 Dopamine and mania. The effects of trans- and cis-clopenthixol in a double-blind pilot study. J Affect Disord 1983 0.84
44 Subthreshold anxiety better defined by symptom self-report than by diagnostic interview. J Affect Disord 2010 0.83
45 Current issues in the identification and management of bipolar spectrum disorders in 'special populations'. J Affect Disord 2000 0.82
46 Pharmacological treatment for psychotic depression. Cochrane Database Syst Rev 2005 0.82
47 Benzodiazepines for depression? A review of the literature. Int Clin Psychopharmacol 1995 0.82
48 Outcome of late-life depression after 3 years of sequential treatment. Acta Psychiatr Scand 2008 0.81
49 The persistence of depression score. Acta Psychiatr Scand 2006 0.81
50 Perceived parental rearing of bipolar offspring. Acta Psychiatr Scand 2007 0.81
51 Berkson's bias and the mood dimensions of bipolar disorder. Int J Methods Psychiatr Res 2009 0.81
52 L-5HTP in depression resistant to re-uptake inhibitors. An open comparative study with tranylcypromine. Br J Psychiatry 1985 0.81
53 The Stanley Foundation Bipolar Network. 2. Preliminary summary of demographics, course of illness and response to novel treatments. Br J Psychiatry Suppl 2001 0.80
54 Increased parental history of bipolar disorder in the United States: association with early age of onset. Acta Psychiatr Scand 2013 0.79
55 Explaining heterogeneity in disability associated with current major depressive disorder: effects of illness characteristics and comorbid mental disorders. J Affect Disord 2010 0.79
56 Explaining heterogeneity in disability with major depressive disorder: effects of personal and environmental characteristics. J Affect Disord 2011 0.79
57 The societal costs and quality of life of patients suffering from bipolar disorder in the Netherlands. Acta Psychiatr Scand 2004 0.79
58 Efficacy and safety of two treatment algorithms in bipolar depression consisting of a combination of lithium, lamotrigine or placebo and paroxetine. Acta Psychiatr Scand 2010 0.79
59 Usefulness of the retrospective Life-Chart method manual in outpatients with a mood disorder: a feasibility study. Patient Educ Couns 2001 0.79
60 Prediction of change in level of problem behavior among children of bipolar parents. Acta Psychiatr Scand 2006 0.78
61 Mood improvement from transcranial magnetic stimulation. Am J Psychiatry 1999 0.78
62 First admissions for mood disorders in immigrants to the Netherlands. Soc Psychiatry Psychiatr Epidemiol 2003 0.78
63 Lithium augmentation in geriatric depression. J Affect Disord 1990 0.77
64 Lateralized neuropsychological functioning in depressive patients before and after drug therapy. Biol Psychiatry 1996 0.77
65 Immune activation, steroid resistancy and bipolar disorder. Bipolar Disord 2002 0.77
66 Premorbid school performance in twins concordant and discordant for bipolar disorder. J Affect Disord 2011 0.76
67 Treatment of bipolar depressive mood disorders: Algorithms for pharmacotherapy. Int J Psychiatry Clin Pract 1997 0.76
68 Changes in outpatient lithium treatment in the Netherlands during 1996-2005. J Affect Disord 2008 0.76
69 Poly I:C in herpetic keratitis in rabbits. Exp Eye Res 1974 0.76
70 Psychotropic drug use in intellectually disabled group-home residents with behavioural problems. Pharmacopsychiatry 2002 0.76
71 Antipsychotic-induced extrapyramidal syndromes in psychiatric practice: a case-control study. Pharm World Sci 2005 0.76
72 Use of quetiapine in bipolar disorder: a case series with prospective evaluation. Int Clin Psychopharmacol 2004 0.76
73 Prevalence of bipolar disorder: a further study in The Netherlands. Bipolar Disord 2002 0.75
74 An open study of triiodothyronine augmentation of tricyclic antidepressants in inpatients with refractory depression. Pharmacopsychiatry 1997 0.75
75 [Depression: longer-lasting episode not an automatic indication for referral]. Ned Tijdschr Geneeskd 2004 0.75
76 A short history of heart surgery. Am Herit 1983 0.75
77 The association between concomitant use of serotonergic antidepressants and lithium-induced polyuria. A multicenter medical chart review study. Pharmacopsychiatry 2008 0.75
78 Brofaromine versus lithium addition to maprotiline. A double-blind study in maprotiline refractory depressed outpatients. J Affect Disord 1994 0.75
79 Basilar artery occlusion, two angiographically demonstrated cases in young women using oral contraceptives. Clin Neurol Neurosurg 1980 0.75
80 [Diagnosis and treatment of bipolar disorder in children]. Ned Tijdschr Geneeskd 2007 0.75
81 Results of the treatment of experimental herpes keratitis with poly I:C. Ophthalmologica 1975 0.75
82 [Lithium in the treatment of depressed elderly patients]. Ned Tijdschr Geneeskd 1990 0.75
83 [Lasting neurologic injury in therapeutic lithium plasma levels]. Ned Tijdschr Geneeskd 1989 0.75
84 [Biological psychiatry - one of the aspects of psychiatric thinking and treatment]. Tijdschr Ziekenverpl 1981 0.75
85 [Seclusion of admitted psychotic patients: later in the case of antipsychotic use and also possibly less often]. Ned Tijdschr Geneeskd 2003 0.75
86 [Lithium]. Ned Tijdschr Geneeskd 1987 0.75
87 The clinical relevance of treatment with antidepressants. Acta Neuropsychiatr 1995 0.75
88 Can you hear me? N Engl J Med 1973 0.75
89 Bellevue: no one was ever turned away. Am Herit 1987 0.75
90 [Rapid cycling in bipolar disorders]. Ned Tijdschr Geneeskd 1994 0.75
91 [Reasons for including the Inventory of Depressive Symptomatology (IDS) and its shortened version (QIDS) in routine outcome monitoring by the Foundation Benchmark Mental Health (SBG)]. Tijdschr Psychiatr 2016 0.75
92 [Are monoamine oxidase inhibitors coming back?]. Ned Tijdschr Geneeskd 1985 0.75
93 Disturbances of liver function of long acting neuroleptic drugs. Pharmakopsychiatr Neuropsychopharmakol 1978 0.75
94 [The role of drug therapy in the treatment of obsessive-compulsive disorders]. Ned Tijdschr Geneeskd 1989 0.75
95 Moderators of the synchrony of change between decreasing depression severity and disability. Acta Psychiatr Scand 2012 0.75
96 [Is it acceptable to use placebos in depression research?]. Tijdschr Psychiatr 2010 0.75
97 [Post-traumatic stress disorder: not only in war victims]. Ned Tijdschr Geneeskd 1989 0.75
98 [Borderline or bipolar disorder after all?]. Ned Tijdschr Geneeskd 1997 0.75
99 [Lamotrigine in the treatment of bipolar disorder, a review]. Tijdschr Psychiatr 2007 0.75
100 Nurses I've know--and you have, too. RN 1969 0.75
101 [Should the treatment of depression in the Netherlands be changed after the STAR*D study?]. Tijdschr Psychiatr 2008 0.75
102 [The treatment of psychotic depression in patients insufficiently responsive to conventional medication and electroconvulsive therapy; what are the options?]. Tijdschr Psychiatr 2008 0.75
103 [Premenstrual syndromes]. Ned Tijdschr Geneeskd 1990 0.75
104 Athletic injuries. The immediate management of abdominal injuries in athletics. Minn Med 1965 0.75
105 [Unipolar depression suddenly switches to hypomania in a patient who has just started taking venlafaxine]. Tijdschr Psychiatr 2006 0.75
106 [Tiapride (Tiapridal) in tardive dyskinesia: another Beelzebub?]. Ned Tijdschr Geneeskd 1982 0.75